|
| |
neotherapeutics irvine, ca Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - neotherapeutics irvine, ca
neotherapeutics irvine, ca - BioPortfolio. ... Mark M. Foreman has been named by NeoTherapeutics (Irvine, CA) as its senior director of research. ...
http://www.bioportfolio.com/search/neotherapeutics_irvine,_c...
|
Vaccine tests key Alzheimer's disease hypothesis - Nature ...
Rajesh Shrotrija, president of NeoTherapeutics (Irvine, CA), says "many of the cognitive tests can take hours, which is exhausting for many patients who are
...
http://www.nature.com/nbt/journal/v19/n2/full/nbt0201_104.ht...
|
AIT-082, a cognitive enhancer, is transported into brain by a ...
NeoTherapeutics Inc., Irvine, CA 92618, USA. etaylor@neotherapeutics.com. A fundamental feature of any drug designed to treat a disease of the central ...
http://www.ncbi.nlm.nih.gov/pubmed/10869380...
|
Promotions, advancements - Nature Biotechnology
NeoTherapeutics (Irvine, CA) has appointed F. Jacob Huff as vice president, medical director. Dr. Huff spent nine years in the neuroscience division of ...
http://www.nature.com/nbt/journal/v19/n1/full/nbt0101_88.htm...
|
Neuroscience - Fifth IBRO World Congress AJ Hannan
AJ Glasky (NeoTherapeutics Inc, Irvine, CA, USA) and ... acid, potassium salt; NeoTherapeutics), a hypoxanthine. derivative. AIT-082 has been found to ...
http://www.biomedcentral.com/content/pdf/cd-378983.pdf...
|
People - Nature Biotechnology
Mark M. Foreman has been named by NeoTherapeutics (Irvine, CA) as its senior director of research. Most recently, Dr. Foreman was director of preclinical ...
http://www.nature.com/nbt/journal/v18/n8/full/nbt0800_903.ht...
|
Therapeutic Approaches to AD: The Paradigm Shifts
Debomoy Lahiri and colleagues[25] from Indiana University School of Medicine, Indianapolis, and NeoTherapeutics, Irvine, California, treated neuronal cells
...
http://www.medscape.com/viewarticle/418413...
|
Regenerative medicine Box 2
NeoTherapeutics (Irvine, CA), for example, has a small molecule called Neotrofin , which crosses the blood–brain barrier to switch on genes for neuronal ...
http://www.nature.com/materials/news/features/010301/nbt0301...
|
Receptor subtype and dose dependence of dexmedetom...[Brain Res ...
NeoTherapeutics, Irvine, California and Department of Pharmacology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. ...
http://www.ncbi.nlm.nih.gov/pubmed/10930558...
|
Comparison of Large Restriction Fragments of Mycobacterium avium ...
We examined potable water in Los Angeles, California, as a possible source of ..... Northridge, Calif.; Ron Ritzman, Neotherapeutics, Irvine, Calif.; ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=88...
|
|
